LEE, JAE WON,李帝元,李帝元,PARK, CHEOL WON,朴哲院,朴哲院,JUN, HUN,田薰,田薰,LEE, TAE WON,李泰远,李泰遠,KIM, NAM HYUCK,金南赫,金南赫,LEE, SUN YOUNG,李宣英,李宣英,YU, JI HYUCK,柳志赫,柳志赫
申请号：
TW103145779
公开号：
TW201605478A
申请日:
2014.12.26
申请国别(地区):
TW
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical combination preparation including an angiotensin-II receptor blocker and an HMG-CoA reductase inhibitor. More particularly, the present invention relates to a pharmaceutical combination preparation which is prepared by a process of granulating a mixture of an angiotensin-II receptor blocker or a pharmaceutically acceptable salt, an alkalinizing agent and a pharmaceutically acceptable additive, and then mixing the granules with the HMG-CoA reductase inhibitor.本發明係關於一種包含血管收縮素-II受體阻斷劑及HMG-CoA還原酶抑制劑之醫藥組合製劑。更特定言之,本發明係關於一種醫藥組合製劑,其係藉由以下方法來製備:使血管收縮素-II受體阻斷劑或醫藥上可接受之鹽、鹼化劑以及醫藥上可接受之添加劑的混合物粒化,並且接著將此等顆粒與該HMG-CoA還原酶抑制劑混合。
